Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $130,265 | 56 | 46.0% |
| Honoraria | $65,550 | 11 | 23.1% |
| Consulting Fee | $39,694 | 24 | 14.0% |
| Travel and Lodging | $38,674 | 95 | 13.6% |
| Food and Beverage | $9,222 | 211 | 3.3% |
| Education | $12.39 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $108,052 | 120 | $0 (2024) |
| ABIOMED | $88,810 | 75 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $26,792 | 35 | $0 (2022) |
| Abbott Laboratories | $25,605 | 57 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $15,270 | 22 | $0 (2024) |
| Medtronic Vascular, Inc. | $12,115 | 46 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $5,304 | 3 | $0 (2024) |
| Allergan Inc. | $358.33 | 1 | $0 (2017) |
| Covidien LP | $200.00 | 1 | $0 (2017) |
| Esperion Therapeutics, Inc. | $169.80 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $38,401 | 34 | ABIOMED ($34,581) |
| 2023 | $36,359 | 34 | ABIOMED ($30,971) |
| 2022 | $38,511 | 55 | ABIOMED ($23,127) |
| 2021 | $21,395 | 30 | AstraZeneca Pharmaceuticals LP ($15,103) |
| 2020 | $20,168 | 33 | AstraZeneca Pharmaceuticals LP ($8,073) |
| 2019 | $42,497 | 69 | Novartis Pharmaceuticals Corporation ($40,530) |
| 2018 | $46,492 | 79 | Novartis Pharmaceuticals Corporation ($31,332) |
| 2017 | $39,593 | 64 | Novartis Pharmaceuticals Corporation ($28,543) |
All Payment Transactions
398 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.72 | General |
| Category: Cardiovascular | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/08/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/12/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.57 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/07/2024 | ABIOMED | Impella (Device) | Travel and Lodging | In-kind items and services | $1,291.95 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/07/2024 | ABIOMED | Impella (Device) | Travel and Lodging | In-kind items and services | $588.06 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/07/2024 | ABIOMED | Impella (Device) | Travel and Lodging | Cash or cash equivalent | $366.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/07/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $46.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/26/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $2.05 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/20/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Consulting Fee | Cash or cash equivalent | $2,300.00 | General |
| Category: Heart Failure | ||||||
| 06/20/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Consulting Fee | Cash or cash equivalent | $718.75 | General |
| Category: Heart Failure | ||||||
| 06/20/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Consulting Fee | Cash or cash equivalent | $575.00 | General |
| Category: Heart Failure | ||||||
| 06/14/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $15.15 | General |
| 06/11/2024 | ABIOMED | Impella (Device) | Travel and Lodging | Cash or cash equivalent | $632.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/11/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $80.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/23/2024 | Cook Medical LLC | ZENITH SPIRAL-Z (Device) | Food and Beverage | Cash or cash equivalent | $95.52 | General |
| Category: Aortic Intervention | ||||||
| 05/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: DIABETES | ||||||
| 05/03/2024 | ABIOMED | Impella (Device) | Honoraria | Cash or cash equivalent | $7,850.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/03/2024 | ABIOMED | Impella (Device) | Travel and Lodging | In-kind items and services | $2,738.31 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/03/2024 | ABIOMED | Impella (Device) | Travel and Lodging | In-kind items and services | $516.06 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/03/2024 | ABIOMED | Impella (Device) | Travel and Lodging | Cash or cash equivalent | $278.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/03/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $125.87 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/18/2024 | ABIOMED | Impella (Device) | Honoraria | Cash or cash equivalent | $7,200.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/18/2024 | ABIOMED | Impella (Device) | Travel and Lodging | In-kind items and services | $999.16 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/18/2024 | ABIOMED | Impella (Device) | Travel and Lodging | In-kind items and services | $356.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 406 | 692 | $275,312 | $67,888 |
| 2022 | 11 | 416 | 694 | $292,055 | $76,425 |
| 2021 | 11 | 335 | 543 | $237,538 | $64,432 |
| 2020 | 13 | 373 | 681 | $288,214 | $70,146 |
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 38 | 99 | $85,135 | $19,788 | 23.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 67 | 106 | $43,898 | $11,629 | 26.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 38 | 75 | $29,411 | $8,257 | 28.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 37 | 51 | $28,982 | $7,866 | 27.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 52 | 81 | $23,424 | $6,093 | 26.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 16 | 16 | $12,764 | $3,167 | 24.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 15 | 19 | $14,016 | $2,915 | 20.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 21 | 39 | $10,764 | $2,884 | 26.8% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 11 | 11 | $13,794 | $2,754 | 20.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 111 | 195 | $13,124 | $2,536 | 19.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 34 | 97 | $83,049 | $20,116 | 24.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 69 | 109 | $43,171 | $11,981 | 27.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 45 | 113 | $42,131 | $10,947 | 26.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 33 | 51 | $28,216 | $8,856 | 31.4% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2022 | 26 | 26 | $32,604 | $7,787 | 23.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 40 | 53 | $15,172 | $4,379 | 28.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 18 | 20 | $11,593 | $3,570 | 30.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 11 | 11 | $8,322 | $2,330 | 28.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 102 | 170 | $11,407 | $2,307 | 20.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $9,040 | $2,262 | 25.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 22 | 28 | $7,350 | $1,889 | 25.7% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 24 | 67 | $57,531 | $14,274 | 24.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 57 | 93 | $37,683 | $10,914 | 29.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 37 | 95 | $34,527 | $9,315 | 27.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 27 | 44 | $24,131 | $7,540 | 31.2% |
About Dr. Alan Gass, MD
Dr. Alan Gass, MD is a Cardiovascular Disease healthcare provider based in East Meadow, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1306847603.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alan Gass, MD has received a total of $283,417 in payments from pharmaceutical and medical device companies, with $38,401 received in 2024. These payments were reported across 398 transactions from 25 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($130,265).
As a Medicare-enrolled provider, Gass has provided services to 1,530 Medicare beneficiaries, totaling 2,610 services with total Medicare billing of $278,891. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location East Meadow, NY
- Active Since 08/09/2005
- Last Updated 12/09/2021
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1306847603
Products in Payments
- ENTRESTO (Drug) $108,029
- Impella (Device) $88,810
- FARXIGA (Drug) $26,725
- LifeVest (Device) $15,270
- CentriMag (Device) $8,592
- HeartWare HVAD (Device) $8,214
- 2ND GEN CENTRIMAG PRIMARY CONSOLE (Device) $7,406
- Circulatory Support (Device) $5,690
- JARDIANCE (Drug) $5,304
- CARDIOMEMS (Device) $3,618
- HeartMate (Device) $127.59
- NEXLIZET (Drug) $125.00
- LINX Reflux Management System (Device) $121.73
- Simulus (Device) $98.55
- ZENITH SPIRAL-Z (Device) $95.52
- VERQUVO (Drug) $80.70
- ELIQUIS (Drug) $61.23
- HeartMate 3 Left Ventricular Dev (Device) $59.03
- XARELTO (Drug) $49.32
- NEXLETOL (Drug) $44.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in East Meadow
Daniel Anghel, Md, MD
Cardiovascular Disease — Payments: $21,645
Mr. Leon Mullen, Md, MD
Cardiovascular Disease — Payments: $5,705
Dr. Ofek Hai, D.o, D.O
Cardiovascular Disease — Payments: $479.01
Barry Saul, Md, MD
Cardiovascular Disease